Clinical Trial

Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy

Name: Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy — clinical trial record (NCT07105384)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Quanti-TAU-PET

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The aim of this clinical trial is to explore the potential of novel 2nd generation tau PET radiotracers as biomarkers in cases suggestive of progressive supranuclear palsy (PSP), an atypical form of parkinsonism.

Trial Details

NCT Number	NCT07105384
Lead Sponsor	Fundacion Clinic per a la Recerca Biomédica
Conditions	Parkinson Disease
Enrollment	66 participants
Start Date	2025-02-04
Primary Completion	2028-06-20 (estimated)
Study Completion	2028-12-20 (estimated)
Updated on ClinicalTrials.gov	2025-08-05